Avaleht › Äge lümfoblastne leukeemia › Ohio › Cincinnati
Äge lümfoblastne leukeemia kliinilised uuringud linnas Cincinnati, OH
12 uuringut haiguse Äge lümfoblastne leukeemia jaoks otsivad osalejaid linnas Cincinnati ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- ja veel 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
VärbamineVaatlusuuring
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
VärbamineFaas 2
- Oncology Hematology Care, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
VärbamineFaas 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
VärbamineFaas 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
VärbamineFaas 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
VärbamineVaatlusuuring
- Children's Hospital Medical Center, Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
VärbamineVaatlusuuring
- Cincinnati Children's Hospital, Cincinnati
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
VärbamineFaas 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
VärbamineVaatlusuuring
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
VärbamineFaas 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
VärbamineFaas 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Äge lümfoblastne leukeemia uuringud teistes linnades
- Houston, TX28 uuringut
- New York City, NY24 uuringut
- Baldwin Park, CA21 uuringut
- Seattle, WA21 uuringut
- Chicago, IL19 uuringut
- Atlanta, GA19 uuringut
- Philadelphia, PA16 uuringut
- Memphis, TN16 uuringut
- Washington, DC16 uuringut
- Boston, MA15 uuringut
- Los Angeles, CA14 uuringut
- Durham, NC13 uuringut
Muud uuringud linnas Cincinnati
- Mitteväikerakuline kopsuvähk35 uuringut
- Vähk (kõik liigid)27 uuringut
- Rinnavähk25 uuringut
- Südamepuudulikkus24 uuringut
- Käär- ja pärasoolevähk21 uuringut
- Äge müeloidne leukeemia20 uuringut
- Metastaatiline vähk20 uuringut
- Munasarjavähk19 uuringut
- Kopsuvähk19 uuringut
- Rasvumine19 uuringut
- Eesnäärmevähk18 uuringut
- Müeloom17 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.